Alcon's board of directors has elected Daniel Vasella to be its new chairman. He steps in for Cary Rayment, who will stay on the board as its vice chairman. Vasella is also chairman at Novartis, which bought a majority of Alcon in August.
Buying a membership today will give you:
To continue reading this article register now.